{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:56:24Z","timestamp":1770335784384,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009563","name":"Fundaci\u00f3n para la Formaci\u00f3n e Investigaci\u00f3n Sanitarias de la Regi\u00f3n de Murcia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009563","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.yexmp.2013.06.011","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T01:48:24Z","timestamp":1372643304000},"page":"151-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence"],"prefix":"10.1016","volume":"95","author":[{"given":"Pablo","family":"Conesa-Zamora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Torres-Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda A","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"P\u00e9rez-Guillermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2013.06.011_bb0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2119\/molmed.2009.00007","article-title":"Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumors","volume":"15","author":"Argyriou","year":"2009","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/ijgc-00009577-200807000-00021","article-title":"Absence of epidermal growth factor receptor mutations in cervical cancer","volume":"18","author":"Arias-Pulido","year":"2008","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00004347-199207000-00009","article-title":"Epidermal growth factor receptor expression and the presence of human papillomavirus in cervical squamous intraepithelial lesions","volume":"11","author":"Chapman","year":"1992","journal-title":"International Journal of Gynecological Pathology"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2407-4-59","article-title":"HER2 expression in cervical cancer as a potential therapeutic target","volume":"4","author":"Chavez-Blanco","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1309\/AJCPO0WY1VIFCYDC","article-title":"Effect of human papillomavirus on cell cycle related proteins p16, Ki67, cyclin D1, p53 and ProEx C in precursor lesions of cervical carcinoma. A tissue microarray study","volume":"132","author":"Conesa-Zamora","year":"2009","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","article-title":"Molecular biology of human papillomavirus infection and cervical cancer","volume":"110","author":"Doorbar","year":"2006","journal-title":"Clinical Science"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0305-7372(03)00068-9","article-title":"Modern management of locally advanced cervical carcinoma","volume":"29","author":"Due\u00f1as-Gonzalez","year":"2003","journal-title":"Cancer Treatment Reviews"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0040","first-page":"OL1373","article-title":"EGFR, p16INK4a and E-cadherin immuno-histochemistry and EGFR point mutations analyses in invasive cervical cancer specimens from Moroccan women","volume":"56","author":"El Hamdani","year":"2010","journal-title":"Cellular and Molecular Biology (Noisy-le-Grand, France)"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0045","first-page":"959","article-title":"The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma","volume":"27","author":"Fuchs","year":"2007","journal-title":"Anticancer Research"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0050","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0055","first-page":"577","article-title":"Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis","volume":"5","author":"Kersemaekers","year":"1999","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/gyno.1996.0039","article-title":"Expression of epidermal growth factor receptor in carcinoma of the cervix","volume":"60","author":"Kim","year":"1996","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1600-0463.2009.02531.x","article-title":"HER2\/neu (c-erbB-2) gene amplification and protein expression are rare in uterine cervical neoplasia: a tissue microarray study of 814 archival specimens","volume":"117","author":"Lesnikova","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/gte.1999.3.237","article-title":"HER-2\/neu oncogene amplification in cervical cancer studied by fluorescent in situ hybridization","volume":"3","author":"Mark","year":"1999","journal-title":"Genetic Testing"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0075","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ejca.2004.03.015","article-title":"Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression","volume":"40","author":"Marzano","year":"2004","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0080","first-page":"637","article-title":"ERBB2 (HER2\/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix","volume":"54","author":"Mitra","year":"1994","journal-title":"Cancer Research"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0085","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2009.26.9571","article-title":"Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer","volume":"28","author":"Monk","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0090","first-page":"5697","article-title":"Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas","volume":"63","author":"Moreno-Bueno","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1383-5718(00)00066-8","article-title":"Association between activated K-ras and c-erbB-2 oncogenes with \u201chigh-risk\u201d and \u201clow-risk\u201d human papilloma virus types in preinvasive cervical lesions","volume":"469","author":"Mour\u00f3n","year":"2000","journal-title":"Mutation Research"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0100","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0959-8049(99)00166-5","article-title":"Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia","volume":"35","author":"Ngan","year":"1999","journal-title":"European Journal of Cancer"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000050613","article-title":"Abnormal expression of epidermal growth factor receptor and c-erbB2 in squamous cell carcinoma of the cervix: correlation with human papillomavirus and prognosis","volume":"22","author":"Ngan","year":"2001","journal-title":"Tumour Biology"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000195539","article-title":"Negative prognostic impact of the coexpression of epidermal growth factor receptor and c-erbB-2 in locally advanced cervical cancer","volume":"76","author":"P\u00e9rez-Regadera","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.pgp.0000092137.88121.8d","article-title":"Overexpression\/amplification of HER-2\/neu is uncommon in invasive carcinoma of the uterine cervix","volume":"23","author":"Rosty","year":"2004","journal-title":"International Journal of Gynecological Pathology"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2407-8-232","article-title":"EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy","volume":"8","author":"Shen","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0125","series-title":"Pathology and Genetics","first-page":"262","article-title":"Tumors of the uterine cervix. Epithelial tumors","author":"Wells","year":"2003"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/2007-131-18-ASOCCO","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"131","author":"Wolff","year":"2007","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0135","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ijrobp.2008.09.005","article-title":"Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer","volume":"74","author":"Yamashita","year":"2009","journal-title":"International Journal of Radiation Oncology, Biology, and Physics"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.yexmp.2013.06.011_bb0145","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ijc.10627","article-title":"Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection","volume":"101","author":"Zhang","year":"2002","journal-title":"International Journal of Cancer"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480013000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480013000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:59:05Z","timestamp":1762145945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480013000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0014480013000762"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2013.06.011","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2013.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}